Bovine mastitis is an inflammatory disease in dairy cattle that causes damage to the mammary glands and leads to reduced milk production.It is caused by bacterial infections such as Staphylococcus aureus and Streptococcus agalactiae. The disease can spread from cow to cow or from environmental contaminants. Advanced mastitis detection products such as enzymes, somatic cell counters, diagnostic kits, and others help detect the presence of mastitis-causing pathogens in milk samples. They enable early diagnosis and timely treatment of the condition, thereby minimizing economic losses for dairy farmers.
Market Opportunity:
The need for effective mastitis detection to minimize financial losses represents a key market opportunity. Mastitis results in reduced milk yields as well as discarded milk during treatment containing antibiotics. According to estimates, bovine mastitis costs the U.S. dairy industry over $2 billion annually. Advanced mastitis detection technologies enable early pathogen identification before clinical signs appear. This helps commence prompt treatment to cure the infection faster and minimize milk discard days. It also helps prevent the spread of mastitis to other cows. The growing recognition of significant economic benefits of early mastitis detection is expected to drive the demand for mastitis diagnostic products over the forecast period.
Porter's Analysis
Threat of new entrants: Low, as the bovine mastitis market requires significant investments in R&D, manufacturing, and distribution to develop effective treatment options and gain market share.
Bargaining power of buyers: Moderate, as large veterinary organizations and dairy farmers can negotiate prices, but treatment options are limited.
Bargaining power of suppliers: Moderate, as key materials and technology providers exist, but development requires specialized expertise.
Threat of new substitutes: Low, as no alternative exists for treating bovine mastitis.
Competitive rivalry: High, as major players compete on innovation, pricing, and marketing to gain market share.
SWOT Analysis
Strengths: Established brands and distribution networks of major players. Increasing dairy consumption driving treatment demand.
Weaknesses: High R&D and manufacturing costs pose challenges. Limited treatment options require further innovations.
Opportunities: Growth in Asian and Latin American dairy industries allows for market expansion. Developing economies increasing veterinary healthcare spending.
Threats: Stringent regulations delay market approvals. Trade barriers could affect supply chains. Rising antibiotic resistance requires alternate therapies.
Key Takeaways
Global Bovine Mastitis Market Size is expected to witness high growth over the forecast period driven by increasing dairy consumption globally.
Regional analysis: The Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to rising dairy production, increasing veterinary healthcare expenditure, and growing animal protein demand in densely populated countries like India and China. This creates opportunities for international players to expand operations in the region.
Key players operating in the bovine mastitis market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Cardinal Health, Lantheus Medical Imaging, Bayer AG, Bracco Imaging, Eczacıbaşı-Monrol Nuclear Products, Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd, IRE – IRE ELiT – Instituto de Pesquisas Energéticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd., Institute of Atomic Energy of Bangladesh, Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT).
Explore More Related Article On This Topic: https://www.ukwebwire.com/global-bovine-mastitis-market-share/
https://masstamilan.in/cancer-therapy-the-future-looks-promising/
Comments
0 comment